Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients

Journal of the Medical Association of Thailand

Volumn 93, Issue 6, 2010, Pages 682-693

  Likidlilid, Atip ^a   Patchanans, Natchai ^a   Peerapatdit, Thavatchai ^a   Sriratanasathavorn, Charn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Antioxidant; Coronary heart disease; Lipid peroxidation; Oxidative stress; Type 2 diabetes

Indexed keywords

ANTIOXIDANT; CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROCYTE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; CASE-CONTROL STUDIES; CATALASE; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 77954498409     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29 (Suppl 1): S43-8.
2. Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 2568-9.
3. Nesto RW. Diabetes and heart disease. In: Krall LP, editor. World book of diabetes in practice. Amsterdam: Elsevier; 1988: 256-9
4. Sozmen EY, Sozmen B, Delen Y, Onat T. Catalase/ superoxide dismutase (SOD) and catalase/ paraoxonase (PON) ratios may implicate poor glycemic control. Arch Med Res 2001; 32: 283-7.
5. Aybek H, Aybek Z, Rota S, Sen N, Akbulut M. The effects of diabetes mellitus, age, and vitamin E on testicular oxidative stress. Fertil Steril 2008; 90: 755-60.
6. Nehru B, Kanwar SS. N-acetylcysteine exposure on lead-induced lipid peroxidative damage and oxidative defense system in brain regions of rats. Biol Trace Elem Res 2004; 101: 257-64.
7. Su Y, Liu XM, Sun YM, Jin HB, Fu R, Wang YY, et al. The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes. Int J Clin Pract 2008; 62: 877-82.
8. Gorogawa S, Kajimoto Y, Umayahara Y, Kaneto H, Watada H, Kuroda A, et al. Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res Clin Pract 2002; 57: 1-10.
9. Schinner S, Scherbaum WA, Bornstein SR, Barthel A. Molecular mechanisms of insulin resistance. Diabet Med 2005; 22: 674-82.
10. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-67.
11. Nacitarhan S, Ozben T, Tuncer N. Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia. Free Radic Biol Med 1995; 19: 893-6.
12. Losada M, Alio JL. Malondialdehyde serum concentration in type 1 diabetic with and without retinopathy. Doc Ophthalmol 1996; 93: 223-9.
13. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001; 17: 189-212.
14. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000; 26: 163-76.
15. Peerapatdit T, Patchanans N, Likidlilid A, Poldee S, Sriratanasathavorn C. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients. J Med Assoc Thai 2006; 89 (Suppl 5): S147-55.
16. Ruhe RC, McDonald RB. Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr 2001; 20 (5 Suppl): 363S-9S.
17. Guerrero-Romero F, Rodriguez-Moran M. Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res 2005; 36: 250-7.
18. Meydani M, Azzi A. Diabetes risk: antioxidants or lifestyle? Am J Clin Nutr 2009; 90: 253-4.
19. Song Y, Cook NR, Albert CM, Van Denburgh M, Manson JE. Effects of vitamins C and E and beta- carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial. Am J Clin Nutr 2009; 90: 429-37.
20. Kalaivanam KN, Dharmalingam M, Marcus SR. Lipid peroxidation in type 2 diabetes mellitus. Int J Diab Dev Ctries 2006; 26: 30-2.
21. King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol 2008; 79: 1527-34.
22. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 1995; 98: 469-75.
23. Beaudeux JL, Guillausseau PJ, Peynet J, Flourie F, Assayag M, Tielmans D, et al. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients. Clin Chim Acta 1995; 239: 131-41.
24. Seghrouchni I, Drai J, Bannier E, Riviere J, Calmard P, Garcia I, et al. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta 2002; 321: 89-96.
25. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996; 90: 255-60.
26. Kesavulu MM, Giri R, Kameswara RB, Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 2000; 26: 387-92.
27. Matkovics B, Varga SI, Szabo L, Witas H. The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res 1982; 14: 77-9.
28. Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998; 21: 1736-42.
29. Parthiban A, Vijayalingam S, Shanmugasundaram KR, Mohan R. Oxidative stress and the development of diabetic complications-antioxidants and lipid peroxidation in erythrocytes and cell membrane. Cell Biol Int 1995; 19: 987-93.
30. Bono A, Caimi G, Catania A, Sarno A, Pandolfo L. Red cell peroxide metabolism in diabetes mellitus. Horm Metab Res 1987; 19: 264-6.
31. Peuchant E, Delmas-Beauvieux MC, Couchouron A, Dubourg L, Thomas MJ, Perromat A, et al. Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients. Diabetes Care 1997; 20: 202-7.
32. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365: 1333-46.
33. Song F, Jia W, Yao Y, Hu Y, Lei L, Lin J, et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin Sci (Lond) 2007; 112: 599-606.
34. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 (Suppl 1): S5-20.
35. Beutler E, West C, Blume KG. The removal of leukocytes and platelets from whole blood. J Lab Clin Med 1976; 88: 328-33.
36. Cynamon HA, Isenberg JN, Nguyen CH. Erythrocyte malondialdehyde release in vitro: a functional measure of vitamin E status. Clin Chim Acta 1985; 151: 169-76.
37. Beutler E. Red cell metabolism: a manual of biochemical methods. New York: Grune and Stratton; 1975.
38. Gowenlack AH, editor. Varley's practical clinical biochemistry. 6th ed. London: Heinemann Medical Books; 1988: 664-5.
39. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
40. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004; 89: 4963-71.
41. Lamarche B, Despres JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec cardiovascular study. Atherosclerosis 1996; 119: 235-45.
42. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997; 17: 1114-20.
43. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992; 85: 37-45.
44. Duvillard L, Pont F, Florentin E, Galland-Jos C, Gambert P, Verges B. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non- insulin-dependent diabetes: a stable isotope kinetic study. Eur J Clin Invest 2000; 30: 685-94.
45. Krauss RM, Siri PW. Dyslipidemia in type 2 diabetes. Med Clin North Am 2004; 88: 897-909.
46. Kastelein JJ, Ordovas JM, Wittekoek ME, Pimstone SN, Wilson WF, Gagne SE, et al. Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women. Clin Genet 1999; 56: 297-305.
47. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987; 28: 613-28.
48. Taskinen MR. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 1992; 41(Suppl 2): 12-7.
49. Yoshino G, Hirano T, Kazumi T. Dyslipidemia in diabetes mellitus. Diabetes Res Clin Pract 1996; 33: 1-14.
50. Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 2000; 23: 1679-85.
51. de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 1999; 26: 202-26.
52. Jacob RA, Burri BJ. Oxidative damage and defense. Am J Clin Nutr 1996; 63: 985S-90S.
53. Gerewal H. Antioxidant and disease prevention.New York: CRC press; 1997.
54. Srivatsan R, Das S, Gadde R, Manoj-Kumar K, Taduri S, Rao N, et al. Antioxidants and lipid peroxidation status in diabetic patients with and without complications. Arch Iran Med 2009; 12: 121-7.
55. de Oliveira FG, Rossi CL, de Oliveira MG, Saad MJ, Velloso LA. Effect of vitamin E supplementation on antibody levels against malondialdehyde modified LDL in hyperlipidemic hamsters. Cardiovasc Res 2000; 47: 567-73.
56. Crouch R, Kimsey G, Priest DG, Sarda A, Buse MG. Effect of streptozotocin on erythrocyte and retinal superoxide dismutase. Diabetologia 1978; 15: 53-7.
57. Gebre-Medhin M, Ewald U, Plantin LO, Tuvemo T. Elevated serum selenium in diabetic children. Acta Paediatr Scand 1984; 73: 109-14.
58. Godin DV, Wohaieb SA, Garnett ME, Goumeniouk AD. Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 1988; 84: 223-31.
59. Yildirim Z, Yildirim F, Ucgun NI, Kilic N. The evaluation of the oxidative stress parameters in nondiabetic and diabetic senile cataract patients. Biol Trace Elem Res 2009; 128: 135-43.
60. Soliman GZ. Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients. Singapore Med J 2008; 49: 129-36.
61. Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 2000; 23: 234-40.
62. Kajanachumpol S, Komindr S, Mahaisiriyodom A. Plasma lipid peroxide and antioxidant levels in diabetic patients. J Med Assoc Thai 1997; 80: 372-7.
63. Dincer Y, Alademir Z, Ilkova H, Akcay T. Susceptibility of glutatione and glutathione- related antioxidant activity to hydrogen peroxide in patients with type 2 diabetes: effect of glycemic control. Clin Biochem 2002; 35: 297-301.
64. Uzel N, Sivas A, Uysal M, Oz H. Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus. Horm Metab Res 1987; 19: 89-90.
65. Pan HZ, Zhang L, Guo MY, Sui H, Li H, Wu WH, et al. The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol 2009 May 28. [Epub ahead of print]. Doi: 10.1007/s00592-009-0128-1.
66. VanderJagt DJ, Harrison JM, Ratliff DM, Hunsaker LA, Vander Jagt DL. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin Biochem 2001; 34: 265-70.
67. Matkovics B, Kotorman M, Varga IS, Hai DQ, Salgo L, Novak Z. Pro-, antioxidant and rheologic studies in the blood of type 2 diabetic patients. Acta Physiol Hung 1997; 85: 107-12.
68. Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 2001; 53: 33-9.
69. Ramakrishna V, Jailkhani R. Oxidative stress in non- insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 2008; 45: 41-6.
70. Kuppusamy UR, Indran M, Ahmad T, Wong SW, Tan SY, Mahmood AA. Comparison of oxidative damage in Malaysian end-stage renal disease patients with or without non-insulin-dependent diabetes mellitus. Clin ChimActa 2005; 351: 197-201.
71. Ookawara T, Kawamura N, Kitagawa Y, Taniguchi N. Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction. Implication of reactive oxygen species. J Biol Chem 1992; 267: 18505-10.
72. Arai K, Iizuka S, Tada Y, Oikawa K, Taniguchi N. Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity. Biochim Biophys Acta 1987; 924: 292-6.
73. Takahashi M, Taniguchi N. Glycation and free radical:fragmentation of Cu, Zn-SOD due to reactive oxygen species. J Act Oxyg Free Rad 1993; 4: 134-41.
74. Rice-Evans CA, Burdon RH. Free radical damage and its control. Amsterdam: Elsevier science; 1994.
75. Komosinska-Vassev K, Olczyk K, Olczyk P, Winsz-Szczotka K. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pract 2005; 68: 207-16.
76. El ghoroury EA, Raslan HM, Badawy EA, El Saaid GS, Agybi MH, Siam I, et al. Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes mellitus: correlation with glycemic control. Blood Coagul Fibrinolysis 2009; 20: 248-51.
77. El Mesallamy H, Hamdy N, Suwailem S, Mostafa S. Oxidative stress and platelet activation: markers of myocardial infarction in type 2 diabetes mellitus. Angiology 2010; 61: 14-8.